Deletion of Apoptosis Inhibitor F1L in Vaccinia Virus Increases Safety and Oncolysis for Cancer Therapy

Vaccinia virus (VACV) possesses a great safety record as a smallpox vaccine and has been intensively used as an oncolytic virus against various types of cancer over the past decade. Different strategies were developed to make VACV safe and selective to cancer cells. Leading clinical candidates, such...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Mol Ther Oncolytics
Main Authors: Pelin, Adrian, Foloppe, Johann, Petryk, Julia, Singaravelu, Ragunath, Hussein, Marian, Gossart, Florian, Jennings, Victoria A., Stubbert, Lawton J., Foster, Madison, Storbeck, Christopher, Postigo, Antonio, Scut, Elena, Laight, Brian, Way, Michael, Erbs, Philippe, Le Boeuf, Fabrice, Bell, John C.
Formato: Artigo
Idioma:Inglês
Publicado em: American Society of Gene & Cell Therapy 2019
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6695278/
https://ncbi.nlm.nih.gov/pubmed/31428674
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.omto.2019.06.004
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados